Magnetization transfer ratio: A potential biomarker for the assessment of postradiation fibrosis in patients with rectal cancer

Investigative Radiology

Volumn 49, Issue 1, 2014, Pages 29-34

  Martens, Milou H ^a,b   Lambregts, Doenja M J ^a   Papanikolaou, Nickolas ^c   Heijnen, Luc A ^a,b   Riedl, Robert G ^a   Zur Hausen, Axel ^a   Maas, Monique ^a   Beets, Geerard L ^a   Beets Tan, Regina G H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c NPapanikolaou and Associates LLC   (Greece)

Author keywords

magnetization transfer ratio; postradiation fibrosis; rectal cancer; response assessment

Indexed keywords

CAPECITABINE PLUS OXALIPLATIN; RAPAMYCIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; MAGNETIZATION TRANSFER RATIO MAGNETIC RESONANCE IMAGING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALGORITHMS; BIOLOGICAL MARKERS; CHEMORADIOTHERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; RADIATION PNEUMONITIS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84890436052     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182a3459b     Document Type: Article

References (38)

1. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(suppl 4):54-56
2. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-And-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29:4633-4640
3. Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006;10:1319-1328
4. Lezoche G, Baldarelli M, Guerrieri M, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc. 2008;22:352-358
5. Borschitz T, Wachtlin D, Mohler M, et al. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol. 2008;15:712-720
6. Glynne-Jones R, Hughes R. Critical appraisal of the ''wait and see'' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg. 2012;99:897-909
7. Vliegen RF, Beets GL, Lammering G, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: Accuracy of MR imaging for prediction. Radiology. 2008;246:454-462
8. Chen CC, Lee RC, Lin JK, et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum. 2005;48:722-728
9. Suppiah A, Hunter IA, Cowley J, et al. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis. 2009;11:249-253
10. Klauss M, Gaida MM, Lemke A, et al. Fibrosis and pancreatic lesions: Counterintuitive behavior of the diffusion imaging-derived structural diffusion coefficient d. Invest Radiol. 2013;48:129-133
11. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: A multicenter study. Ann Surg Oncol. 2011;18:2224-2231
12. Nezafat R, Han Y, Peters DC, et al. Coronary magnetic resonance vein imaging: Imaging contrast, sequence, and timing. Magn Reson Med. 2007;58:1196-1206
13. Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: A review. NMR Biomed. 2001;14:57-64
14. Karampekios S, Papanikolaou N, Papadaki E, et al. Quantification of magnetization transfer rate and native T1 relaxation time of the brain: Correlation with magnetization transfer ratio measurements in patients with multiple sclerosis. Neuroradiology. 2005;47:189-196
15. Papanikolaou N, Papadaki E, Karampekios S, et al. T2 relaxation time analysis in patients with multiple sclerosis: Correlation with magnetization transfer ratio. Eur Radiol. 2004;14:115-122
16. Papanikolaou N, Maniatis V, Pappas J, et al. Biexponential T2 relaxation time analysis of the brain: Correlation with magnetization transfer ratio. Invest Radiol. 2002;37:363-367
17. Wachsmuth L, Juretschke HP, Raiss RX. Can magnetization transfer magnetic resonance imaging follow proteoglycan depletion in articular cartilage? MAGMA. 1997;5:71-78
18. Kumar V, Jagannathan NR, Kumar R, et al. Evaluation of the role of magnetization transfer imaging in prostate: A preliminary study. Magn Reson Imaging. 2008;26:644-649
19. Bonini RH, Zeotti D, Saraiva LA, et al. Magnetization transfer ratio as a predictor of malignancy in breast lesions: Preliminary results. Magn Reson Med. 2008;59:1030-1034
20. Leong CS, Daniel BL, Herfkens RJ, et al. Characterization of breast lesion morphology with delayed 3DSSMT: An adjunct to dynamic breast MRI. J Magn Reson Imaging. 2000;11:87-96
21. Papanikolaou N, Ghiatas A, Kattamis A, et al. Non-invasive myocardial iron assessment in thalassaemic patients. T2 relaxometry and magnetization transfer ratio measurements. Acta Radiol. 2000;41:348-351
22. Adler J, Swanson SD, Schmiedlin-Ren P, et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology. 2011;259:127-135
23. Li W, Zhang Z, Nicolai J, et al. Magnetization transfer MRI in pancreatic cancer xenograft models. Magn Reson Med. 2012;68:1291-1297
24. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999
25. Matsushima S, Sasaki F, Kinosada Y, et al. Saturation transfer ratio imaging in invasive ductal carcinomas of the breast. Magn Reson Imaging. 2000;18:379-385
26. Miese F, Kircheis G, Wittsack HJ, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol. 2006;27: 1019-1026
27. Kim H, Booth CJ, Pinus AB, et al. Induced hepatic fibrosis in rats: Hepatic steatosis, macromolecule content, perfusion parameters, and their correlationsVpreliminary MR imaging in rats. Radiology. 2008;247:696-705
28. Rosenkrantz AB, Storey P, Gilet AG, et al. Magnetization transfer contrastprepared MR imaging of the liver: Inability to distinguish healthy from cirrhotic liver. Radiology. 2012;262:136-143
29. Dresen RC, Beets GL, Rutten HJ, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology. 2009;252:71-80
30. Capirci C, Rubello D, Chierichetti F, et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: Role of F18-FDG PET. Biomed Pharmacother. 2004;58:451-457
31. Gollub MJ, Gultekin DH, Akin O, et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol. 2011;22:821-831
32. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: Assessment of complete response to preoperative combined radiation therapy with chemotherapyVconventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011;260:734-743
33. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-And radiation therapy. Radiology. 2009;253:116-125
34. Song I, Kim SH, Lee SJ, et al. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: Comparison with T2 weighted and PET/CT imaging. Br J Radiol. 2011;85:577-586
35. Lambrecht M, Deroose C, Roels S, et al. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol. 2010;49:956-963
36. Kim SH, Lee JY, Lee JM, et al. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol. 2010;21:987-995
37. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 2010;254:170-178
38. Martirosian P, Boss A, Deimling M, et al. Systematic variation of off-resonance prepulses for clinical magnetization transfer contrast imaging at 0.2, 1.5, and 3.0 tesla. Invest Radiol. 2008;43:16-26